Author

Oxana Lungu

Institution: University of Parma

Observed institution: University of Parma

OpenAlex ID: A5041835532

Mechanistic insights into bone destruction in multiple myeloma: Cellular and molecular perspectives

2025 · Oxana Lungu, Denise Toscani, et al. · Journal of bone oncology · 16

The Metabolic Features of Osteoblasts: Implications for Multiple Myeloma (MM) Bone Disease

2023 · Oxana Lungu, Denise Toscani, et al. · International Journal of Molecular Sciences · 10

PDF

High glutamate levels in the bone marrow of multiple myeloma patients promote osteoclast formation: a novel target for osteolytic bone disease

2025 · Denise Toscani, Oxana Lungu, et al. · Leukemia · 7

PDF

Identification of PSMB4 and PSMD4 as novel target genes correlated with 1q21 amplification in patients with smoldering myeloma and multiple myeloma

2023 · Jessica Burroughs Garcia, Paola Storti, et al. · Haematologica · 7

PDF

CD38 expression by plasma cells in extramedullary multiple myeloma

2023 · Laura Notarfranchi, Fabrizio Accardi, et al. · Haematologica · 4

PDF

Follow-up of humoral and cellular immune responses after the third SARS-CoV-2 vaccine dose in multiple myeloma patients

2025 · Vincenzo Raimondi, Paola Storti, et al. · Frontiers in Immunology · 2

PDF

P-092: Impaired glutamine/glutamate metabolic axis into myeloma microenvironment affects osteoclast formation.

2022 · Denise Toscani, Martina Chiu, et al. · Clinical Lymphoma Myeloma & Leukemia · 2

Long-term prognostic impact of chromosome 1 abnormalities in newly diagnosed multiple myeloma patients: a monocentric study

2026 · Nicolas Thomas Iannozzi, Gabriella Sammarelli, et al. · Annals of Hematology · 1

PYGO2-MDR1 Axis in Multiple Myeloma Patients with 1q21 Amplification As Promising Target to Overcome Carfilzomib Resistance

2023 · Nicolas Thomas Iannozzi, Jessica Burroughs Garcia, et al. · Blood · 1

PA-056 Bortezomib-Based Regimen Significantly Reduces Bone Resorption Rate Compared to Lenalidomide-Based in Newly Diagnosed Elderly Multiple Myeloma Patients: Results from the Italian Real Phase IV Trial

2026 · Denise Toscani, Oxana Lungu, et al. · Clinical Lymphoma Myeloma & Leukemia

PYGO2 is overexpressed in multiple myeloma patients with 1q21 amplification, driving plasma cell proliferation and cell cycle progression

2026 · Nicolas Thomas Iannozzi, Paola Storti, et al. · Cancer Gene Therapy

PDF

Oncolytic bovine herpesvirus type 1 induces immune microenvironment remodeling and enhances treatment responses in multiple myeloma

2026 · Vincenzo Raimondi, Rosanna Vescovini, et al. · Haematologica

Altered osteoblast populations dynamics underlie myeloma progression from precursors diseases in bone microenvironment

2025 · Mattia Dessena, Fazel Mohammadi, et al. · Blood

PDF

Single Cell Transcriptomics on Bone Marrow Biopsies Unveils Peculiar Bone Microenvironment Cell Subtypes and Highlights Alterations Correlated with High-Risk Features in Precursor Monoclonal Gammopathies and Multiple Myeloma Patients

2024 · Mattia Dessena, Tommaso Torelli, et al. · Blood

Bovine Herpes Virus Type 1 Oncolytic Therapy Elicits Direct Cytotoxic Effects and Immune Microenvironment Reshaping in Multiple Myeloma

2024 · Vincenzo Raimondi, Paola Storti, et al. · Blood

P-269 Pygo2 Is Overexpressed in Myeloma Cells With 1q21 Amplification Being Involved in Carfilzomib Resistance

2024 · Nicolas Thomas Iannozzi, Paola Storti, et al. · Clinical Lymphoma Myeloma & Leukemia

Abstract 6848: Analysis of the bone microenvironment cells by single cell transcriptomics reveals altered features in multiple myeloma patients compared to pre-malignant monoclonal gammopathies

2024 · Paola Storti, Tommaso Torelli, et al. · Cancer Research

P-180 PYGO2 is upregulated in multiple myeloma patients with 1q21+: a potential novel therapeutic target

2023 · Jessica Burroughs Garcia, Nicolas Thomas Iannozzi, et al. · Clinical Lymphoma Myeloma & Leukemia

P830: Identification of Novel Target Genes Correlated With 1q21 Amplification in Patients With Smoldering Myeloma and Multiple Myeloma

2023 · Nicolas Thomas Iannozzi, Jessica Burroughs Garcia, et al. · HemaSphere

Glutamate Metabolism Shapes Osteoclast Differentiation: New Potential Therapeutic Target to Block Osteoclastic Bone Resorption in Multiple Myeloma Patients

2022 · Denise Toscani, Oxana Lungu, et al. · Blood

Identification of the Proteasome Subunits PSMB4 and PSMD4 As Novel Targets in Multiple Myeloma Patients Carrying 1q21 Amplification

2022 · Jessica Burroughs Garcia, Paola Storti, et al. · Blood

Works count: 21

Citation count: 50

H-index: 4

I10-index: 2